TY  - GEN
AU  - Imai,Hisao
AU  - Kaira,Kyoichi
AU  - Mori,Keita
AU  - Kotake,Mie
AU  - Mitani,Masumi
AU  - Kawashima,Naoko
AU  - Hisada,Takeshi
AU  - Minato,Koichi
TI  - Post-progression survival is highly linked to overall survival in patients with non-small-cell lung cancer harboring sensitive EGFR mutations treated with first-line epidermal growth factor receptor-tyrosine kinase inhibitors
SN  - 1759-7714
PY  - 2020///0810
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Carcinoma, Non-Small-Cell Lung
KW  - diagnosis
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Exons
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/1759-7714.13193
ER  -